Komo Announces Product of the Year Nomination by the B.C. Food and Beverage Association Life Science Investing
Bristol Myers Squibb Announces Adjuvant Treatment with Opdivo Demonstrated Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival in Patients with Stage IIB/C Melanoma in the CheckMate -76K Trial Pharmaceutical Investing
Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate in Adolescents Life Science Investing
AbbVie to Present Data from Growing Neuroscience and Movement Disorders Portfolio at 2022 MDS International Congress Pharmaceutical Investing
Danaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company Medical Device Investing
AbbVie Announces Public Voting Open for 30th Annual Cystic Fibrosis Scholarship "Thriving Student Awards" Pharmaceutical Investing
Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes 2022 Life Science Investing
BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling Pharmaceutical Investing
Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations Pharmaceutical Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
